Rules on reporting trials must be better enforced, say health integrity groups

BMJ 2017; 359: j5786
Author: Deborah Cohen
“Unregulated reporting of clinical trials opens the door to fraud and corruption, undermining medical advances and public health objectives, a report has warned. The report, by a consortium of “health integrity organisations,” urges governments to enforce current rules to ensure that patients, doctors, and scientists can access the full results of all clinical trials.”
Find article here.

Red Cross: $6 Million Meant to Fight Ebola Was Stolen Through Fraud

Time, 6 November 2017
Authors: Clarence Roy-Macaulay, Krista Larson
“Fraud by Red Cross workers and others wasted at least $6 million meant to fight the deadly Ebola outbreak in West Africa, the organization confirmed Saturday. The revelations follow an internal investigation of how the organization handled more than $124 million during the 2014-2016 epidemic that killed more than 11,000 people in Sierra Leone, Liberia and Guinea.”
Find article here.

The Boston-Area Pharmacist Involved in a Deadly Meningitis Outbreak Has Been Cleared of Murder

Time, 26 October 2017
Author: Alanna Durkin Richer
“A pharmacist at a facility whose tainted drugs sparked a nationwide meningitis outbreak that killed 76 people was cleared Wednesday of murder but was convicted of mail fraud and racketeering.”
Find article here.

Corruption Poses Critical Challenge to Global Health Efforts

JAMA. 2017;318(15):1431.
Author: M.J. Friedrich
“This article explores the scope and variety of fraudulent conduct in health services and discusses emerging anticorruption tools and interagency frameworks that could limit corruption. Data and technology can play a big role in improving transparency and accountability. Online social network platforms can be used as educational tools to increase public awareness about corruption as well as to increase citizen participation in monitoring and reporting of corruption. Efforts aimed at analysis and mining of large reimbursement data sets can also detect health care fraud.”
Find article here.

China vows to clamp down on academic fraud amid medical journal scandal

BMJ 2017; 357: j2970
Author: Jane Parry
“China’s Ministry of Science and Technology has said that it is investigating the case of 107 papers from China retracted by the journal Tumor Biology in April this year and that it has “zero tolerance” for academic fraud. The papers were retracted after the journal’s publisher, Springer, conducted a manual screening that showed that the authors had submitted papers with fake email addresses for reviewers.”
Find article here.

Two Medicare Advantage Insurers Settle Whistleblower Lawsuit For $32 Million

KHN, 30 May 2017
Author: Fred Schulte
“Two Florida Medicare Advantage insurers have agreed to pay nearly $32 million to settle a whistleblower lawsuit that alleged they exaggerated how sick patients were and took other steps to overbill the government health plan for the elderly.”
Find article here.

Pelvic mesh devices hit by allegations of research fraud, experimental surgery on thousands of women

SMH, 14 March 2017
Author: Joanne McCarthy
“Pelvic devices developed in Australia from the 1980s and 1990s are at the centre of a global medical scandal that includes regulatory failure, and allegations of research fraud and experimental surgery on women in multiple countries.”
Find article here.